TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
NVAX

Novavax Inc

Healthcare · Biotechnology

10.50$ -1.3% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Novavax Inc (NVAX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 956 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NVAX
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
460 394 362 356 334 302 276 286 250 208 221 189 165 173 328 932 944 1,582 2,608 2,750 2,566 2,577 2,835 2,623 2,267 2,259 1,543 1,685 1,657 1,797 1,354 1,819 1,712 1,560 1,293 1,337 1,180 1,177 1,043 956
354 288 258 237 226 203 181 194 161 119 123 110 89 97 255 636 671 1,248 2,247 2,355 2,174 2,155 2,347 2,136 1,760 1,703 971 1,128 1,007 1,144 727 1,203 1,104 1,129 868 920 975 978 851 771
120 144 96 76 104 106 113 88 56 70 98 72 71 79 180 424 334 553 1,995 2,075 1,937 1,515 1,571 1,376 1,281 1,337 625 506 651 569 481 680 574 530 263 254 268 241 228 191
300 144 211 187 173 106 144 167 127 70 100 72 71 79 237 502 504 711 1,998 2,075 1,937 1,515 1,571 1,376 1,281 1,337 625 506 651 569 481 1,050 910 923 731 612 763 735 790 719
0.6 0.2 0.8 0.8 0.9 38 0.9 – – -70 – – – 7.5 7.5 0.0 16 262 102 71 110 455 478 195 112 82 113 395 124 297 21 32 95 108 45 226 34 106 23 19
32 16 0.0 0.0 0.0 13 13 0.0 0.0 12 12 – – -83 – – 67 -167 32 -2,098 8.2 8.9 107 256 82 37 34 23 70 42 16 9.2 8.6 8.7 10 10 14 12 11 10
41 40 39 39 37 36 32 31 29 28 27 13 12 11 11 115 132 180 192 213 215 229 247 340 256 400 307 300 492 – – – – – – – – – – –
53 52 52 53 54 54 53 52 52 52 51 51 50 51 50 119 127 135 131 134 132 131 131 123 118 126 130 128 124 127 123 123 127 107 112 113 113 113 113 113
10.0 9.2 9.2 9.5 8.1 7.9 7.6 6.9 6.8 6.5 6.1 6.0 5.5 5.6 5.1 5.3 5.3 5.7 5.3 5.3 5.0 4.8 4.5 4.0 8.5 – – – – – – – – – – – – – – –
410 400 391 415 408 404 375 374 377 376 372 375 355 359 352 748 838 955 1,569 2,004 2,105 2,928 2,770 3,040 2,833 2,893 2,438 2,440 2,336 2,514 2,221 2,250 2,239 2,184 1,369 1,299 1,337 1,304 1,188 1,146
76 66 56 67 68 74 45 43 47 46 31 41 22 26 19 213 239 322 1,209 1,652 1,753 2,390 2,261 2,156 1,668 2,460 1,919 1,596 1,469 1,635 804 1,158 1,181 1,154 422 389 430 460 342 331
0.0 30 27 27 30 35 21 27 23 25 3.5 19 1.2 1.3 12 44 56 322 121 98 104 131 440 448 407 352 1.2 1.0 1.3 5.1 6.3 9.4 9.7 7.0 5.5 5.6 5.0 2.5 2.1 4.1
16 5.7 3.8 8.0 5.2 5.6 5.8 6.7 6.8 9.3 6.2 4.3 4.2 2.9 2.5 9.2 15 54 114 74 60 127 135 386 145 217 125 87 102 133 58 80 58 42 34 51 15 25 16 23
316 316 317 317 317 318 318 318 319 319 320 320 320 321 321 321 322 322 322 323 323 323 – – – 166 167 167 168 168 168 169 169 170 170 171 244 244 291 291
50 -5.5 -29 -59 -74 -102 -99 -88 -127 -168 -151 -185 -190 -186 -24 185 106 627 1,039 746 461 -352 65 -417 -566 -634 -896 -755 -678 -717 -867 -432 -526 -624 -76 38 -157 -128 -145 -191
-873 -930 -974 -1,019 -1,064 -1,114 -1,161 -1,205 -1,250 -1,299 -1,342 -1,382 -1,400 -1,432 -1,458 -1,499 -1,697 -1,874 -2,097 -2,449 -2,772 -3,618 -3,415 -3,925 -4,094 -4,276 -4,570 -4,512 -4,643 -4,821 -4,969 -4,806 -4,927 -5,008 -4,490 -4,383 -4,586 -4,568 -4,578 -4,631
14 14 14 14 15 16 17 19 19 19 20 23 24 28 44 59 62 66 73 74 75 74 81 78 78 80 86 104 103 124 140 166 160 160 178 177 162 173 163 165

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?